We are live on ! Find out more
VASC

Vascular Solutions Inc
VASC

Delisted

VASC was delisted on the 17th of February, 2017.

104 hedge funds and large institutions have $256M invested in Vascular Solutions Inc in 2014 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 33 increasing their positions, 31 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 9

12% more capital invested

Capital invested by funds: $227M → $256M (+$28.2M)

5% more funds holding

Funds holding: 99104 (+5)

6% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 31

0% more call options, than puts

Call options by funds: $7K | Put options by funds: $7K

Holders
104
Holders Change
+5
Holders Change %
+5.05%
% of All Funds
3.02%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
14
Increased
33
Reduced
31
Closed
9
Calls
$7K
Puts
$7K
Net Calls
Net Calls Change
-$13K

VASC Hedge Fund Activity: Q3 2014 in Review

104 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Vascular Solutions Inc (VASC) for Q3 2014, worth a combined $256M — up 12% from $227M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new VASC positions and 9 closed out — a net gain of 5 holders — while 33 added to existing stakes and 31 trimmed.

The largest buyer was Conestoga Capital Advisors, opening a new position worth an estimated $2.96M. The largest seller was Argent Capital Management, cutting an estimated $1.44M.

  • 104 institutional investors held Vascular Solutions Inc (VASC) as of Q3 2014, up from 99 in Q2 2014.
  • Funds reported $256M of Vascular Solutions Inc stock for Q3 2014, up 12% quarter-over-quarter.
  • 14 funds opened new Vascular Solutions Inc positions in Q3 2014 and 9 closed out, a net change of +5 holders.
  • The largest Vascular Solutions Inc buyer in Q3 2014 was Conestoga Capital Advisors, an estimated $2.96M added.
  • The largest Vascular Solutions Inc seller in Q3 2014 was Argent Capital Management, an estimated $1.44M sold.

Based on aggregated 13F filings for Q3 2014.